The FDA Recently selected psilocybin for a breakthrough therapy for therapy-resistant depression. Breakthrough status expedites drugs which might be believed to Exhibit benefits about existing medical therapies. When ingested, the body metabolizes the psilocybin into psilocin via enzymes in the liver. The psilocin then functions within the serotonin receptors — http://httpa://trippywanderhouse.com